Fast Five Quiz: Oncology Pain Management

Winston W. Tan, MD

Disclosures

July 19, 2021

Mu receptor antagonists (eg, naloxone) must be used in the treatment of opioid-induced respiratory depression. Psychostimulants (eg, methylphenidate) to treat opioid-induced sedation are recommended only when other methods have been tried first and failed.

The use of naloxone in association with oxycodone or methylnaltrexone to control OIC may be considered. While naloxegol has been shown to be highly effective in OIC, there are no data specific to persons with cancer.

Learn more about palliative management of cancer pain.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....